Anders Essen-Möller
Förmögenhet: 674 317 $ per 2026-09-30
Förmögenhet: 674 317 $ per 2026-09-30
Anders Essen-Möller was the founder of Mertiva AB, founded in 1976, where the title held was Director from 2013 to 2014.
Mr. Essen-Möller was the founder of Synectics Medical AB, founded in 2015, where the title held was Chief Executive Officer & Director from 2015 to 2016.
Mr. Essen-Möller is the founder of Diamyd Medical AB, founded in 1996, where the title held is Chief Executive Officer & Director starting in 2026.
Current jobs include Director at Companion Medical, Inc., Director at Diamyd Diagnostics AB, and Director at Armea AB. Former jobs include Chairman at NextCell Pharma AB from 2018 to 2024 and Director at Novakand Pharma AB from 2010 to 2012.
Education includes a graduate degree from the University of Lund.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 5 297 192 ( 3,5 % ) | 546 776 $ | 2026-09-30 | |
DIAMYD MEDICAL AB 35,27 % | 2026-03-31 | 1 235 620 ( 35,27 % ) | 127 541 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| DIAMYD MEDICAL AB | Grundare | 1996-01-01 |
Diamyd Diagnostics AB | Direktör/Styrelseledamot | 2011-05-10 |
Armea AB | Direktör/Styrelseledamot | 2011-05-10 |
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| NEXTCELL PHARMA AB | Ordförande | 2024-05-20 |
Synectics Medical AB
Synectics Medical AB Information Technology ServicesTechnology Services Develops computer support systems for health care industry | Grundare | 2016-04-10 |
| MERTIVA AB | Grundare | 2014-02-21 |
| KANCERA AB | Direktör/Styrelseledamot | 2012-03-28 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Health Technology |
Mertiva AB
Mertiva AB Financial ConglomeratesFinance Operates as an investment company | Finance |
Synectics Medical AB
Synectics Medical AB Information Technology ServicesTechnology Services Develops computer support systems for health care industry | Technology Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kancera AB
Kancera AB Pharmaceuticals: MajorHealth Technology Develops drugs against inflammation and cancer | Health Technology |
Diamyd Medical AB
Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
Diamyd Diagnostics AB | |
Armea AB | |
NextCell Pharma AB
NextCell Pharma AB Pharmaceuticals: MajorHealth Technology Develops investigational medicinal products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån